Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic Adenocarcinoma.

Lin C, Verma V, Lazenby A, Ly QP, Berim LD, Schwarz JK, Madiyalakan M, Nicodemus CF, Hollingsworth MA, Meza JL, Are C, Padussis J, Grem JL.

Am J Clin Oncol. 2019 Oct;42(10):755-760. doi: 10.1097/COC.0000000000000599.

PMID:
31513018
2.

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019.

Gupta S, Provenzale D, Llor X, Halverson AL, Grady W, Chung DC, Haraldsdottir S, Markowitz AJ, Slavin TP Jr, Hampel H; CGC, Ness RM, Weiss JM, Ahnen DJ, Chen LM, Cooper G, Early DS, Giardiello FM, Hall MJ, Hamilton SR, Kanth P, Klapman JB, Lazenby AJ, Lynch PM, Mayer RJ, Mikkelson J; CGC, Peter S, Regenbogen SE, Dwyer MA; CGC, Ogba N.

J Natl Compr Canc Netw. 2019 Sep 1;17(9):1032-1041. doi: 10.6004/jnccn.2019.0044.

PMID:
31487681
3.

Phase I trial of concurrent stereotactic body radiotherapy and nelfinavir for locally advanced borderline or unresectable pancreatic adenocarcinoma.

Lin C, Verma V, Ly QP, Lazenby A, Sasson A, Schwarz JK, Meza JL, Are C, Li S, Wang S, Hahn SM, Grem JL.

Radiother Oncol. 2019 Mar;132:55-62. doi: 10.1016/j.radonc.2018.11.002. Epub 2018 Dec 20.

PMID:
30825970
4.

NCCN Guidelines Insights: Colorectal Cancer Screening, Version 1.2018.

Provenzale D, Gupta S, Ahnen DJ, Markowitz AJ, Chung DC, Mayer RJ, Regenbogen SE, Blanco AM, Bray T, Cooper G, Early DS, Ford JM, Giardiello FM, Grady W, Hall MJ, Halverson AL, Hamilton SR, Hampel H, Klapman JB, Larson DW, Lazenby AJ, Llor X, Lynch PM, Mikkelson J, Ness RM, Slavin TP, Sugandha S, Weiss JM, Dwyer MA, Ogba N.

J Natl Compr Canc Netw. 2018 Aug;16(8):939-949. doi: 10.6004/jnccn.2018.0067.

PMID:
30099370
5.

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017.

Gupta S, Provenzale D, Regenbogen SE, Hampel H, Slavin TP, Hall MJ, Llor X, Chung DC, Ahnen DJ, Bray T, Cooper G, Early DS, Ford JM, Giardiello FM, Grady W, Halverson AL, Hamilton SR, Klapman JB, Larson DW, Lazenby AJ, Lynch PM, Markowitz AJ, Mayer RJ, Ness RM, Samadder NJ, Shike M, Sugandha S, Weiss JM, Dwyer MA, Ogba N.

J Natl Compr Canc Netw. 2017 Dec;15(12):1465-1475. doi: 10.6004/jnccn.2017.0176.

PMID:
29223984
6.

The Apoptotic Crypt Abscess: An Underappreciated Histologic Finding in Gastrointestinal Pathology.

Talmon G, Manasek T, Miller R, Muirhead D, Lazenby A.

Am J Clin Pathol. 2017 Nov 20;148(6):538-544. doi: 10.1093/ajcp/aqx100.

PMID:
29140405
7.

A computable pathology report for precision medicine: extending an observables ontology unifying SNOMED CT and LOINC.

Campbell WS, Karlsson D, Vreeman DJ, Lazenby AJ, Talmon GA, Campbell JR.

J Am Med Inform Assoc. 2017 Sep 13. doi: 10.1093/jamia/ocx097. [Epub ahead of print]

PMID:
29024958
8.

MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.

Shukla SK, Purohit V, Mehla K, Gunda V, Chaika NV, Vernucci E, King RJ, Abrego J, Goode GD, Dasgupta A, Illies AL, Gebregiworgis T, Dai B, Augustine JJ, Murthy D, Attri KS, Mashadova O, Grandgenett PM, Powers R, Ly QP, Lazenby AJ, Grem JL, Yu F, Matés JM, Asara JM, Kim JW, Hankins JH, Weekes C, Hollingsworth MA, Serkova NJ, Sasson AR, Fleming JB, Oliveto JM, Lyssiotis CA, Cantley LC, Berim L, Singh PK.

Cancer Cell. 2017 Sep 11;32(3):392. doi: 10.1016/j.ccell.2017.08.008. No abstract available.

9.

De Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer.

Tadros S, Shukla SK, King RJ, Gunda V, Vernucci E, Abrego J, Chaika NV, Yu F, Lazenby AJ, Berim L, Grem J, Sasson AR, Singh PK.

Cancer Res. 2017 Oct 15;77(20):5503-5517. doi: 10.1158/0008-5472.CAN-16-3062. Epub 2017 Aug 15.

10.

Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis.

Roe JS, Hwang CI, Somerville TDD, Milazzo JP, Lee EJ, Da Silva B, Maiorino L, Tiriac H, Young CM, Miyabayashi K, Filippini D, Creighton B, Burkhart RA, Buscaglia JM, Kim EJ, Grem JL, Lazenby AJ, Grunkemeyer JA, Hollingsworth MA, Grandgenett PM, Egeblad M, Park Y, Tuveson DA, Vakoc CR.

Cell. 2017 Aug 24;170(5):875-888.e20. doi: 10.1016/j.cell.2017.07.007. Epub 2017 Jul 27.

11.

MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.

Shukla SK, Purohit V, Mehla K, Gunda V, Chaika NV, Vernucci E, King RJ, Abrego J, Goode GD, Dasgupta A, Illies AL, Gebregiworgis T, Dai B, Augustine JJ, Murthy D, Attri KS, Mashadova O, Grandgenett PM, Powers R, Ly QP, Lazenby AJ, Grem JL, Yu F, Matés JM, Asara JM, Kim JW, Hankins JH, Weekes C, Hollingsworth MA, Serkova NJ, Sasson AR, Fleming JB, Oliveto JM, Lyssiotis CA, Cantley LC, Berim L, Singh PK.

Cancer Cell. 2017 Jul 10;32(1):71-87.e7. doi: 10.1016/j.ccell.2017.06.004. Erratum in: Cancer Cell. 2017 Sep 11;32(3):392.

12.

Chronic mesenteric ischemia and gastric ischemia: a bad combination.

Ahmad DS, Sahak K, Lazenby AJ, Bhat I.

Gastrointest Endosc. 2017 Sep;86(3):564-565. doi: 10.1016/j.gie.2017.02.030. Epub 2017 Mar 7. No abstract available.

PMID:
28283323
13.

Myeloid-derived cullin 3 promotes STAT3 phosphorylation by inhibiting OGT expression and protects against intestinal inflammation.

Li X, Zhang Z, Li L, Gong W, Lazenby AJ, Swanson BJ, Herring LE, Asara JM, Singer JD, Wen H.

J Exp Med. 2017 Apr 3;214(4):1093-1109. doi: 10.1084/jem.20161105. Epub 2017 Mar 9.

14.

Dosimetric parameters correlate with duodenal histopathologic damage after stereotactic body radiotherapy for pancreatic cancer: Secondary analysis of a prospective clinical trial.

Verma V, Lazenby AJ, Zheng D, Bhirud AR, Ly QP, Are C, Sasson AR, Lin C.

Radiother Oncol. 2017 Mar;122(3):464-469. doi: 10.1016/j.radonc.2016.12.030. Epub 2017 Jan 12.

15.

Massive adrenal vein aneurysm mimicking an adrenal tumor in a patient with hemophilia A: a case report and review of the literature.

Sleightholm R, Wahlmeier S, Carson JS, Drincic A, Lazenby A, Foster JM.

J Med Case Rep. 2016 Dec 1;10(1):343. Review.

16.

Up-regulation of N-cadherin by Collagen I-activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1.

Huang H, Svoboda RA, Lazenby AJ, Saowapa J, Chaika N, Ding K, Wheelock MJ, Johnson KR.

J Biol Chem. 2016 Oct 28;291(44):23208-23223. Epub 2016 Sep 7.

17.

Mucins and associated O-glycans based immunoprofile for stratification of colorectal polyps: clinical implication for improved colon surveillance.

Krishn SR, Kaur S, Sheinin YM, Smith LM, Gautam SK, Patel A, Jain M, Juvvigunta V, Pai P, Lazenby AJ, Roy HK, Batra SK.

Oncotarget. 2017 Jan 24;8(4):7025-7038. doi: 10.18632/oncotarget.12347.

18.

Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

Provenzale D, Gupta S, Ahnen DJ, Bray T, Cannon JA, Cooper G, David DS, Early DS, Erwin D, Ford JM, Giardiello FM, Grady W, Halverson AL, Hamilton SR, Hampel H, Ismail MK, Klapman JB, Larson DW, Lazenby AJ, Lynch PM, Mayer RJ, Ness RM, Regenbogen SE, Samadder NJ, Shike M, Steinbach G, Weinberg D, Dwyer M, Darlow S.

J Natl Compr Canc Netw. 2016 Aug;14(8):1010-30.

PMID:
27496117
19.

Incidence of Gastric Cancer in Marrakech and Casablanca, Morocco.

Smith BL, Khouchani M, Karkouri M, Lazenby AJ, Watkins K, Tahri A, Benider AL, Rajaram S, Soliman AS.

J Cancer Epidemiol. 2015;2015:704569. doi: 10.1155/2015/704569. Epub 2015 Oct 21.

20.

Colorectal Cancer Screening, Version 1.2015.

Provenzale D, Jasperson K, Ahnen DJ, Aslanian H, Bray T, Cannon JA, David DS, Early DS, Erwin D, Ford JM, Giardiello FM, Gupta S, Halverson AL, Hamilton SR, Hampel H, Ismail MK, Klapman JB, Larson DW, Lazenby AJ, Lynch PM, Mayer RJ, Ness RM, Rao MS, Regenbogen SE, Shike M, Steinbach G, Weinberg D, Dwyer MA, Freedman-Cass DA, Darlow S; National comprehensive cancer netwok.

J Natl Compr Canc Netw. 2015 Aug;13(8):959-68; quiz 968.

PMID:
26285241
21.

The first fistula: influence of location on catheter use and the influence of catheter use on maturation.

Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB, Lazenby A.

Int Urol Nephrol. 2015 Sep;47(9):1571-5. doi: 10.1007/s11255-015-1062-5. Epub 2015 Aug 4.

PMID:
26238945
22.

MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism.

Shukla SK, Gunda V, Abrego J, Haridas D, Mishra A, Souchek J, Chaika NV, Yu F, Sasson AR, Lazenby AJ, Batra SK, Singh PK.

Oncotarget. 2015 Aug 7;6(22):19118-31.

23.

Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation.

Souchek JJ, Baine MJ, Lin C, Rachagani S, Gupta S, Kaur S, Lester K, Zheng D, Chen S, Smith L, Lazenby A, Johansson SL, Jain M, Batra SK.

Br J Cancer. 2014 Sep 9;111(6):1139-49. doi: 10.1038/bjc.2014.385. Epub 2014 Jul 15.

24.

Whole slide imaging diagnostic concordance with light microscopy for breast needle biopsies.

Campbell WS, Hinrichs SH, Lele SM, Baker JJ, Lazenby AJ, Talmon GA, Smith LM, West WW.

Hum Pathol. 2014 Aug;45(8):1713-21. doi: 10.1016/j.humpath.2014.04.007. Epub 2014 Apr 24.

PMID:
24913758
25.

Ezrin expression and cell survival regulation in colorectal cancer.

Leiphrakpam PD, Rajput A, Mathiesen M, Agarwal E, Lazenby AJ, Are C, Brattain MG, Chowdhury S.

Cell Signal. 2014 May;26(5):868-79. doi: 10.1016/j.cellsig.2014.01.014. Epub 2014 Jan 22.

26.

Colorectal cancer screening.

Burt RW, Cannon JA, David DS, Early DS, Ford JM, Giardiello FM, Halverson AL, Hamilton SR, Hampel H, Ismail MK, Jasperson K, Klapman JB, Lazenby AJ, Lynch PM, Mayer RJ, Ness RM, Provenzale D, Rao MS, Shike M, Steinbach G, Terdiman JP, Weinberg D, Dwyer M, Freedman-Cass D; National comprehensive cancer network.

J Natl Compr Canc Netw. 2013 Dec 1;11(12):1538-75.

PMID:
24335688
27.

Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.

Remmers N, Anderson JM, Linde EM, DiMaio DJ, Lazenby AJ, Wandall HH, Mandel U, Clausen H, Yu F, Hollingsworth MA.

Clin Cancer Res. 2013 Apr 15;19(8):1981-93. doi: 10.1158/1078-0432.CCR-12-2662. Epub 2013 Feb 27.

28.

Collagenous colitis in children and adolescents: study of 7 cases and literature review.

Liu X, Xiao SY, Plesec TP, Jiang W, Goldblum JR, Lazenby AJ.

Mod Pathol. 2013 Jun;26(6):881-7. doi: 10.1038/modpathol.2012.227. Epub 2013 Jan 25. Review.

29.

Concordance between whole-slide imaging and light microscopy for routine surgical pathology.

Campbell WS, Lele SM, West WW, Lazenby AJ, Smith LM, Hinrichs SH.

Hum Pathol. 2012 Oct;43(10):1739-44. doi: 10.1016/j.humpath.2011.12.023. Epub 2012 May 14.

PMID:
22591912
30.

Gastric adenocarcinoma with chief cell differentiation: a proposal for reclassification as oxyntic gland polyp/adenoma.

Singhi AD, Lazenby AJ, Montgomery EA.

Am J Surg Pathol. 2012 Jul;36(7):1030-5. doi: 10.1097/PAS.0b013e31825033e7.

PMID:
22472957
31.

Differential expression of metabolic genes in tumor and stromal components of primary and metastatic loci in pancreatic adenocarcinoma.

Chaika NV, Yu F, Purohit V, Mehla K, Lazenby AJ, DiMaio D, Anderson JM, Yeh JJ, Johnson KR, Hollingsworth MA, Singh PK.

PLoS One. 2012;7(3):e32996. doi: 10.1371/journal.pone.0032996. Epub 2012 Mar 7.

32.

Translocation t(12;17)(q24.1;q21) as the sole anomaly in a nasal chondromesenchymal hamartoma arising in a patient with pleuropulmonary blastoma.

Behery RE, Bedrnicek J, Lazenby A, Nelson M, Grove J, Huang D, Smith R, Bridge JA.

Pediatr Dev Pathol. 2012 May-Jun;15(3):249-53. doi: 10.2350/11-11-1121-CR.1. Epub 2012 Feb 22.

PMID:
22356457
33.

NCCN clinical practice guidelines in oncology. Colorectal cancer screening.

Burt RW, Barthel JS, Dunn KB, David DS, Drelichman E, Ford JM, Giardiello FM, Gruber SB, Halverson AL, Hamilton SR, Ismail MK, Jasperson K, Lazenby AJ, Lynch PM, Martin EW Jr, Mayer RJ, Ness RM, Provenzale D, Rao MS, Shike M, Steinbach G, Terdiman JP, Weinberg D; NCCN.

J Natl Compr Canc Netw. 2010 Jan;8(1):8-61. No abstract available.

PMID:
20064289
34.

Sinonasal teratocarcinosarcoma: report of a case with review of literature and treatment outcome.

Wei S, Carroll W, Lazenby A, Bell W, Lopez R, Said-Al-Naief N.

Ann Diagn Pathol. 2008 Dec;12(6):415-25. doi: 10.1016/j.anndiagpath.2007.05.003. Epub 2007 Oct 24. Review.

PMID:
18995206
35.

Multiple gastrointestinal stromal tumors and lipomatosis.

Liu X, Wilcox CM, Nodit L, Lazenby AJ.

Arch Pathol Lab Med. 2008 Nov;132(11):1825-9. doi: 10.1043/1543-2165-132.11.1825.

PMID:
18976023
36.

A dialysis patient with blurred vision.

Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB, Lazenby A.

NDT Plus. 2008 Aug;1(4):250-2. doi: 10.1093/ndtplus/sfn007. Epub 2008 Apr 9. No abstract available.

37.

Graft-versus-host-like disease complicating thymoma: lack of AIRE expression as a cause of non-hereditary autoimmunity?

Offerhaus GJ, Schipper ME, Lazenby AJ, Montgomery E, Morsink FH, Bende RJ, Musler AR, van Lier RA, van Noesel CJ.

Immunol Lett. 2007 Nov 30;114(1):31-7. Epub 2007 Sep 29.

PMID:
17928069
38.

Resolution of nonalcoholic steatohepatits after gastric bypass surgery.

Liu X, Lazenby AJ, Clements RH, Jhala N, Abrams GA.

Obes Surg. 2007 Apr;17(4):486-92.

PMID:
17608261
39.

Surgical management of a giant thoracic angiomyolipoma.

Holman WL, Diethelm L, Lazenby AJ, Winokur TS, Lyerly RT 3rd, Cerfolio RJ.

Ann Thorac Surg. 2007 Jun;83(6):2201-3.

PMID:
17532427
40.

Influence of liver biopsy heterogeneity and diagnosis of nonalcoholic steatohepatitis in subjects undergoing gastric bypass.

Arun J, Jhala N, Lazenby AJ, Clements R, Abrams GA.

Obes Surg. 2007 Feb;17(2):155-61.

PMID:
17476865
41.

The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women.

Arun J, Clements RH, Lazenby AJ, Leeth RR, Abrams GA.

Obes Surg. 2006 Oct;16(10):1351-8.

PMID:
17059746
42.

Cytomegalovirus blocks intestinal stroma-induced down-regulation of macrophage HIV-1 infection.

Maheshwari A, Smythies LE, Wu X, Novak L, Clements R, Eckhoff D, Lazenby AJ, Britt WJ, Smith PD.

J Leukoc Biol. 2006 Nov;80(5):1111-7.

PMID:
17056764
43.

Signal transduction cross-talk during colorectal tumorigenesis.

Liu X, Lazenby AJ, Siegal GP.

Adv Anat Pathol. 2006 Sep;13(5):270-4. Review.

PMID:
16998321
44.

Collagenous and lymphocytic colitis.

Lazenby AJ.

Semin Diagn Pathol. 2005 Nov;22(4):295-300. Review.

PMID:
16939057
45.

Prospective endoscopic evaluation for gastrointestinal graft-versus-host disease: determination of the best diagnostic approach.

Thompson B, Salzman D, Steinhauer J, Lazenby AJ, Wilcox CM.

Bone Marrow Transplant. 2006 Sep;38(5):371-6.

PMID:
16915225
46.

Diagnostic quality of: polyps resected by snare polypectomy: does the type of electrosurgical current used matter?

Fry LC, Lazenby AJ, Mikolaenko I, Barranco B, Rickes S, Mönkemüller K.

Am J Gastroenterol. 2006 Sep;101(9):2123-7. Epub 2006 Jul 18.

PMID:
16848810
47.

Diverticular colitis.

Lazenby AJ.

Adv Exp Med Biol. 2005;563:30-4. Review. No abstract available.

PMID:
16433120
48.

Rab11a immunohistochemical analysis does not distinguish indefinite, low-, and high-grade dysplasia in Barrett esophagus.

Robert ME, Washington MK, Lee JR, Goldenring JR, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart JA, Lamps LW, Lauwers GY, Lewin D, Lazenby AJ, Montgomery E, Crawford JM.

Am J Clin Pathol. 2005 Oct;124(4):519-27.

PMID:
16146818
49.

Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women.

Kunde SS, Lazenby AJ, Clements RH, Abrams GA.

Hepatology. 2005 Sep;42(3):650-6.

PMID:
16037946
50.

Signet-ring-cell adenocarcinoma arising from a hyperplastic polyp in the stomach.

Fry LC, Lazenby AJ, Lee DH, Mönkemüller K.

Gastrointest Endosc. 2005 Mar;61(3):493-5. No abstract available.

PMID:
15758936

Supplemental Content

Loading ...
Support Center